HomeCompareNRBT vs CL

NRBT vs CL: Dividend Comparison 2026

NRBT yields 9756.10% · CL yields 2.43%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NRBT wins by $43230381229833840.00M in total portfolio value
10 years
NRBT
NRBT
● Live price
9756.10%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43230381229833840.00M
Annual income
$42,375,942,331,967,610,000,000.00
Full NRBT calculator →
CL
CL
● Live price
2.43%
Share price
$85.73
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$40.8K
Annual income
$5,401.96
Full CL calculator →

Portfolio growth — NRBT vs CL

📍 NRBT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNRBTCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NRBT + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NRBT pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NRBT
Annual income on $10K today (after 15% tax)
$829,268.29/yr
After 10yr DRIP, annual income (after tax)
$36,019,550,982,172,465,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$206.23/yr
After 10yr DRIP, annual income (after tax)
$4,591.67/yr
At 15% tax rate, NRBT beats the other by $36,019,550,982,172,465,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NRBT + CL for your $10,000?

NRBT: 50%CL: 50%
100% CL50/50100% NRBT
Portfolio after 10yr
$21615190614916920.00M
Annual income
$21,187,971,165,983,804,000,000.00/yr
Blended yield
98.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

NRBT
No analyst data
Altman Z
1.7
Piotroski
3/9
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+7.8% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NRBT buys
0
CL buys
0
No recent congressional trades found for NRBT or CL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNRBTCL
Forward yield9756.10%2.43%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$43230381229833840.00M$40.8K
Annual income after 10y$42,375,942,331,967,610,000,000.00$5,401.96
Total dividends collected$43173501257510792.00M$18.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NRBT vs CL ($10,000, DRIP)

YearNRBT PortfolioNRBT Income/yrCL PortfolioCL Income/yrGap
1← crossover$986,310$975,609.76$11,012$312.01+$975.3KNRBT
2$90,985,578$89,930,226.22$12,196$412.95+$90.97MNRBT
3$7,850,557,226$7,753,202,657.96$13,599$549.66+$7850.54MNRBT
4$633,609,188,528$625,209,092,296.54$15,288$736.64+$633609.17MNRBT
5$47,836,734,147,594$47,158,772,315,868.44$17,353$995.28+$47836734.13MNRBT
6$3,378,690,702,500,742$3,327,505,396,962,816.50$19,926$1,357.80+$3378690702.48MNRBT
7$223,260,494,299,726,370$219,645,295,248,050,560.00$23,194$1,873.82+$223260494299.70MNRBT
8$13,803,319,479,942,732,000$13,564,430,751,042,025,000.00$27,439$2,621.52+$13803319479942.71MNRBT
9$798,541,026,043,208,800,000$783,771,474,199,670,000,000.00$33,088$3,727.38+$798541026043208.75MNRBT
10$43,230,381,229,833,840,000,000$42,375,942,331,967,610,000,000.00$40,806$5,401.96+$43230381229833840.00MNRBT

NRBT vs CL: Complete Analysis 2026

NRBTStock

Novus Robotics Inc., through its subsidiary, D&R Technology Inc., engages in engineering, designing, manufacturing, and selling automated tube processing solutions for the automotive industry worldwide. The company designs and installs retrofits to existing automated systems, as well as offers spare parts, maintenance, and repair and production support services to automotive tier I businesses and their suppliers. Its products include seat frame systems, IP tube systems, and integrated bend-weld systems. The company also provides value added services, including system upgrades and rebuilds, control system upgrades, tooling retrofits, pre-production and prototyping requirements, training, equipment relocation and redeployment, systems audit, manufacturing consulting, and project management services. The company offers its products to automotive seating manufacturers and manufacturers of tubing products. Novus Robotics Inc. was founded in 2004 and is based in Mississauga, Canada.

Full NRBT Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this NRBT vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NRBT vs SCHDNRBT vs JEPINRBT vs ONRBT vs KONRBT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.